Skip to main content
RAPS Convergence 2022 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
  1. Home

RAPS Convergence 2022 Planning Committee

A special thank you to the Convergence 2022 Planning Committee for making this year’s conference possible.

Committee Leaders

 
Kimberly Belsky
Kimberly Belsky
(Chair)
Executive Director, Reg Policy & Intel, AdPromo, and RegOps, Regulatory Affairs
Mallinckrodt Pharmaceuticals
Megha Deviprasad Iyer
Megha  Deviprasad Iyer
(Vice Chair)
Director, Global Strategic Regulatory Affairs
Thermo Fisher Scientific
Gert Bos
Gert Bos
(RAPS Board of Directors Representative)
Executive Director & Partner
Qserve China

Committee Members

Bassil Akra
Bassil Akra

Chief Executive Officer, Akra Team

 Lisa Baumhardt
Lisa Baumhardt

Senior Medical Device Regulation Expert, Hyman, Phelps & McNamara

 Francis Dekker
Francis Dekker

Senior Regulatory Affairs Manager, Thermofisher Scientific
João Duarte
João Duarte

Director, Chief of Staff & Regulatory Science, Alexion Pharmaceuticals

 Niedre Heckman
Niedre Heckman

Director, CMC and Devices/Combination Products, Global Reg. Affairs, Takeda

 Linda McBride
Linda McBride

Biopharmaceuticals Consultant</p
Erin Oliver
Erin Oliver

Head, US Regulatory Affairs, GlaxoSmithKline Consumer Healthcare

 George Serafin
George Serafin

Senior Managing Director, Fti Consulting

 Chris Whalley
Chris Whalley

Associate Director, Regulatory Policy & Intelligence, Seagen
   
Sabine Haubenreisser
Sabine Haubenreisser

EMA Liaison, Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency

 Katie Rivers
Katie Rivers

FDA Liaison, Project Manager, U.S. Food and Drug Administration